Citigroup
OPNT

Citigroup’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Citigroup’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20
Closed – – 6562
2022
Q2 		$0 Buy
20
+10
+100% +$161 ﹤0.01% 6845
2022
Q1 		$0 Buy
+10
New +$265 ﹤0.01% 6778

Other funds holding OPNT

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's OPNT Position: Q3 2022 in Review

Citigroup sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q3 2022, closing a stake of 20 shares.

Citigroup first reported a position in OPNT in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 32 funds tracked by Wall St. Rank hold OPNT as of Q3 2022.

  • Citigroup reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 20 Opiant Pharmaceuticals, Inc. Common Stock shares in Q3 2022.
  • Citigroup first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Citigroup's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $0 in Q2 2022.
  • 32 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.